229 related articles for article (PubMed ID: 14635016)
21. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
[TBL] [Abstract][Full Text] [Related]
22. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients.
Vogelberg C; Meyer-König U; Hufert FT; Kirste G; von Laer D
J Med Virol; 1996 Sep; 50(1):31-4. PubMed ID: 8890038
[TBL] [Abstract][Full Text] [Related]
23. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
[TBL] [Abstract][Full Text] [Related]
25. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients.
Pellegrin I; Garrigue I; Ekouevi D; Couzi L; Merville P; Merel P; Chene G; Schrive MH; Trimoulet P; Lafon ME; Fleury H
J Infect Dis; 2000 Jul; 182(1):36-42. PubMed ID: 10882579
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype.
Aquino VH; Figueiredo LT
J Med Virol; 2000 May; 61(1):138-42. PubMed ID: 10745246
[TBL] [Abstract][Full Text] [Related]
27. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
[TBL] [Abstract][Full Text] [Related]
29. Identification of cytomegalovirus (CMV) infection by different laboratory methods in renal transplant recipients undergoing triple-drug immunosupressive treatment.
Siennicka J; Durlik M; Litwińska B; Chmura A; Lewandowska D; Lao M; Paczek L; Kańtoch M
Acta Microbiol Pol; 1999; 48(1):61-71. PubMed ID: 10467696
[TBL] [Abstract][Full Text] [Related]
30. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
[TBL] [Abstract][Full Text] [Related]
31. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients.
Coaquette A; Bourgeois A; Dirand C; Varin A; Chen W; Herbein G
Clin Infect Dis; 2004 Jul; 39(2):155-61. PubMed ID: 15307021
[TBL] [Abstract][Full Text] [Related]
32. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
33. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
[TBL] [Abstract][Full Text] [Related]
34. Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.
Gerna G; Baldanti F; Lilleri D; Parea M; Torsellini M; Castiglioni B; Vitulo P; Pellegrini C; Viganò M; Grossi P; Revello MG
Transplantation; 2003 Apr; 75(7):1012-9. PubMed ID: 12698090
[TBL] [Abstract][Full Text] [Related]
35. Is combined pretransplantation seropositivity of kidney transplant recipients for cytomegalovirus antigens (pp150 and pp28) a predictor for protection against infection?
Essa S; Pacsa A; Said T; Nampoory MR; Raghupathy R; Johny KV; Al-Nakib W; Al-Mosawy M
Med Princ Pract; 2008; 17(1):66-70. PubMed ID: 18059104
[TBL] [Abstract][Full Text] [Related]
36. Differential detection of cytomegalovirus immediate-early messenger RNA in clinical samples using ligation-dependent PCR.
Wu F; Li H; Zhang DY
Mol Diagn; 2001 Dec; 6(4):233-9. PubMed ID: 11774188
[TBL] [Abstract][Full Text] [Related]
37. Comparison of cytomegalovirus pp-65 antigenemia assay and plasma DNA correlation with the clinical outcome in transplant recipients.
de Oña M; Melón S; Galarraga MC; Palacio A; Lambert JL; Bernardo MJ; Rodríguez M; Gómez E
Transpl Int; 2005 Jan; 18(1):43-6. PubMed ID: 15612982
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
Humar A; Kumar D; Gilbert C; Boivin G
J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
[TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role.
Lafarge X; Merville P; Cazin MC; Bergé F; Potaux L; Moreau JF; Déchanet-Merville J
J Infect Dis; 2001 Sep; 184(5):533-41. PubMed ID: 11494158
[TBL] [Abstract][Full Text] [Related]
40. Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients.
Kanaan A; Cour I; Alvarez-Lafuente R; Benedicto M; Culebras E; Prats D; Fernández C; Picazo JJ
Int J Antimicrob Agents; 2004 Nov; 24(5):455-62. PubMed ID: 15519477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]